[EN] QUINAZOLINE COMPOUNDS<br/>[FR] COMPOSES DE QUINAZOLINE
申请人:HOFFMANN LA ROCHE
公开号:WO2004092144A2
公开(公告)日:2004-10-28
The present invention relates to compounds of formula (I), wherein R4, R5, R6, R7, Q, m and n are as defined in the specification. The compounds are useful as p38 kinase inhibitors, and therefore, may be used for treatment of p38-mediated disorder.
Substituted quinazoline compounds useful as P38 kinase inhibitors
申请人:——
公开号:US20040209904A1
公开(公告)日:2004-10-21
Compounds having the formula (I),
1
are useful as p38 kinase inhibitors, wherein R
4
and R
5
are hydrogen, halogen, cyano, haloalkyl, or haloalkoxy, but are not both hydrogen; R
6
and R
7
are optional substituents, and Q is a non-aromatic moiety as defined in the specification.